Kirk Shepard. M.D.

Kirk Shepard. M.D.

Chief Medical OfficeratPDS Biotechnology· In proxies 2023–2025

Pay in FY2025-49% from the year before · PDS Biotechnology stock -52.8% the same year

Kirk Shepard. M.D. was paid $677.3K in FY2025 (Dec), down 49%. PDS Biotechnology stock fell 52.8% that year.

Pay$100 in the stock at the end of FY22 → $6
Pay is from the Summary Compensation Table of each PDS Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PDS BiotechnologyPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role -83%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?